All In MedTech

Device Trial Radar · NCT06025708

Quantra QStat Sample Type Comparison

Impact of Sample Type on the Performance of the Quantra QStat System

Last checked: Nov 20, 2026Latest source record: May 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Sep 11, 2023

Primary completion

Jan 5, 2024

Study completion Mar 1, 2024

Sponsor

Lead sponsor
HemoSonics LLCNot on our public-company list
Sponsor type
Industry
First posted
Sep 6, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a single center prospective observational study to compare QStat parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing liver transplantation.

Conditions

  • Coagulation Defect; Bleeding

Interventions

  • Diagnostic Test: Quantra QStat CartridgeDevice

    Whole blood coagulation testing system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of QStat Clot time (CT) in arterial and venous samplesTime frame: During liver transplantation surgery
  2. Comparison of QStat Clot stiffness (CS) in arterial and venous samplesTime frame: During liver transplantation surgery
  3. Comparison of QStat Platelet Contribution to Clot stiffness (PCS) in arterial and venous samplesTime frame: During liver transplantation surgery

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ohio State University Wexner Medical Center

    Columbus, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.